Marketplace of Human Specimen Procurement for Research

iSpecimen Marketplace: Where Discovery Meets Efficiency

The iSpecimen Marketplace transforms the process of acquiring and contributing human biospecimens for research. Powered by proprietary technology, our vast network of qualified biospecimen partners offers instant access to millions of richly characterized specimens.

Visit the Marketplace and Search for Free

80%

of researchers limit research due to lack of biospecimens

91%

of biorepositories report sustainability is a concern

24,301,000

of biospecimens available in the iSpecimen Marketplace

“The iSpecimen Marketplace allows us to reach thousands of scientists.”

Amer Abouhamze, MHA, Assistant Director, CTSI Biorepository, University of Florida

“iSpecimen enabled us to immediately expand our sourcing of tumor types that we did not have a channel for.”

David Deems, President, Cellaria

“This process previously required a lot of paperwork and time. iSpecimen makes it so much easier and quicker.”

LeeAnn Talarico, Prinicipal Investigator, SQZ Biotech

“Our partnership with iSpecimen allows us to expand our reach across the scientific community, providing specimens directly for the discovery of new diagnostics and therapeutics.”

Eric Carbonneau, MS, MT (ASCP), Director of Core Lab Operations & Research Institute, TriCore Solutions

News & Events

May 8, 2019

Life sciences data and informatics expert Dave John has joined iSpecimen as vice president of product management. Dave brings nearly two decades of experience in business development, product management, and executive leadership to the challenge of helping researchers procure human biospecimens for their work. Specimens encompass both inherent biological data (including genetics) as well as clinical information about the patients who provided them (including demographics, treatments and outcomes). Both data types help streamline discovery of increasingly specific specimens for specialized research. Read more.

March 12, 2019

iSpecimen Founder and CEO Christopher Ianelli, MD, PhD, will appear on a panel of senior executives exploring hot technologies and topics in molecular medicine tomorrow at Molecular Med TRI-CON here in San Francisco. Read more.

March 4, 2019

iSpecimen today announced that researchers and suppliers are joining the iSpecimen Marketplace at a robust rate, with both populations more than doubling yearly since the Marketplace was introduced in mid-2017. Read more.